Proof of Concept Study Demonstrates Potential Treatment for Metastatic Hepatocellular Carcinoma
According to a story from bioportfolio.com, the biopharmaceutical company Eureka Therapeutics recently released the results of the proof of concept trial for its experimental T-cell therapy ET140202 as a treatment…